TickerFacts.

Context Therapeutics Inc. (CNTX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$66.00M
As of 2025-12-31
$42.99M
As of 2026-06-30
+23.0%
3-year compound annual growth
n/m
5-year compound annual growth
$94.43M2020-12-31: $290.7K2021-12-31: $49.64M2022-12-31: $35.50M2023-12-31: $14.45M2024-12-31: $94.43M2025-12-31: $66.00M$66.00M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$66.00M-30.1%2026-03-23, Balance as of period end
2024-12-31$94.43M+553.5%2026-03-23, Balance as of period end
2023-12-31$14.45M-59.3%2025-03-20, Balance as of period end
2022-12-31$35.50M-28.5%2024-03-21, Balance as of period end
2021-12-31$49.64Mn/m2023-03-22, Balance as of period end
2020-12-31$290.7Kn/a2022-03-23, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Context Therapeutics Inc. (CNTX)2025-12-31$66.00M-30.1%
Spero Therapeutics, Inc. (SPRO)2025-12-31$40.27M-23.9%
Werewolf Therapeutics, Inc. (HOWL)2025-12-31$57.05M-48.6%
Grace Therapeutics, Inc. (GRCE)2026-03-31$16.98M-23.3%
Corvus Pharmaceuticals, Inc. (CRVS)2025-12-31$4.58M-47.6%
Aldeyra Therapeutics, Inc. (ALDX)2025-12-31$70.04M+28.5%
Inovio Pharmaceuticals, Inc. (INO)2025-12-31$44.27M-32.7%
Rallybio Corp (RLYB)2025-12-31$31.37M+125.7%
OnKure Therapeutics, Inc. (OKUR)2025-12-31$59.05M-46.7%

Compare CNTX, SPRO, HOWL, GRCE side by side · Screen every company in Pharmaceutical Preparations ↗